EDIT vs ILMN · rev $32.3M vs rev $4.34B
Editas Medicine Inc (EDIT) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
EDIT currently screens at market cap $375.2M. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the EDIT and ILMN stock pages for the full models.
Not investment advice.